BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03924856-completion@plaintrial.com
DTSTAMP:20261028T114003Z
DTSTART;VALUE=DATE:20260901
SUMMARY:Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy
  Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-
 eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) 
 — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03924856
URL:https://plaintrial.com/trial/NCT03924856
END:VEVENT
END:VCALENDAR